# First-line pembrolizumab in PD-L1 positive non-small-cell lung cancer: A cost-effectiveness analysis from the UK health care perspective

> Research article (Lung Cancer, 2018) · cited 44× · AI/ML

**Wikidata**: [openalex:W2836887652](https://www.wikidata.org/wiki/openalex:W2836887652)  
**Source**: https://4ort.xyz/entity/first-line-pembrolizumab-in-pd-l1-positive-non-small-cell-lung-cancer-a-cost-effectiveness-analysis-from-the-uk-health-c